Skip to main content
Premium Trial:

Request an Annual Quote

Whatman to Acquire Schleicher & Schuell for 50.2M Euros

NEW YORK, Nov. 8 (GenomeWeb News) - Whatman announced today its proposed acquisition of Schleicher & Schuell for €50.2 million ($65 million).

 

According to Whatman, the acquisition, which will be financed in full by debt, gives it the opportunity to expand its presence in Europe, while achieving cost and revenue synergies as early as next year.

 

The announcement comes about four months after Whatman terminated a licensing deal with Schleicher & Schuell as part of a patent infringement lawsuit settlement.

 

Whatman noted that the acquisition is still subject to approval at an extraordinary general meeting scheduled for Nov. 30.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.